-
Knicks boost win streak to six by beating LeBron's Lakers
-
Kendrick Lamar, Bad Bunny, Lady Gaga triumph at Grammys
-
Japan says rare earth found in sediment retrieved on deep-sea mission
-
San Siro prepares for last dance with Winter Olympics' opening ceremony
-
France great Benazzi relishing 'genius' Dupont's Six Nations return
-
Grammy red carpet: black and white, barely there and no ICE
-
Oil tumbles on Iran hopes, precious metals hit by stronger dollar
-
South Korea football bosses in talks to avert Women's Asian Cup boycott
-
Level playing field? Tech at forefront of US immigration fight
-
British singer Olivia Dean wins Best New Artist Grammy
-
Hatred of losing drives relentless Alcaraz to tennis history
-
Kendrick Lamar, Bad Bunny, Lady Gaga win early at Grammys
-
Surging euro presents new headache for ECB
-
Djokovic hints at retirement as time seeps away on history bid
-
US talking deal with 'highest people' in Cuba: Trump
-
UK ex-ambassador quits Labour over new reports of Epstein links
-
Trump says closing Kennedy Center arts complex for two years
-
Reigning world champs Tinch, Hocker among Millrose winners
-
Venezuelan activist ends '1,675 days' of suffering in prison
-
Real Madrid scrape win over Rayo, Athletic claim derby draw
-
PSG beat Strasbourg after Hakimi red to retake top spot in Ligue 1
-
NFL Cardinals hire Rams' assistant LaFleur as head coach
-
Arsenal scoop $2m prize for winning FIFA Women's Champions Cup
-
Atletico agree deal to sign Lookman from Atalanta
-
Real Madrid's Bellingham set for month out with hamstring injury
-
Man City won't surrender in title race: Guardiola
-
Korda captures weather-shortened LPGA season opener
-
Czechs rally to back president locking horns with government
-
Prominent Venezuelan activist released after over four years in jail
-
Emery riled by 'unfair' VAR call as Villa's title hopes fade
-
Guirassy double helps Dortmund move six points behind Bayern
-
Nigeria's president pays tribute to Fela Kuti after Grammys Award
-
Inter eight clear after win at Cremonese marred by fans' flare flinging
-
England underline World Cup
credentials with series win over Sri Lanka
-
Guirassy brace helps Dortmund move six behind Bayern
-
Man City held by Solanke stunner, Sesko delivers 'best feeling' for Man Utd
-
'Send Help' debuts atop N.America box office
-
Ukraine war talks delayed to Wednesday, says Zelensky
-
Iguanas fall from trees in Florida as icy weather bites southern US
-
Carrick revels in 'best feeling' after Man Utd leave it late
-
Olympic chiefs admit 'still work to do' on main ice hockey venue
-
Pope says Winter Olympics 'rekindle hope' for world peace
-
Last-gasp Demirovic strike sends Stuttgart fourth
-
Sesko strikes to rescue Man Utd, Villa beaten by Brentford
-
'At least 200' feared dead in DR Congo landslide: government
-
Coventry says 'sad' about ICE, Wasserman 'distractions' before Olympics
-
In-form Lyon make it 10 wins in a row
-
Man Utd strike late as Carrick extends perfect start in Fulham thriller
-
Van der Poel romps to record eighth cyclo-cross world title
-
Mbappe penalty earns Real Madrid late win over nine-man Rayo
Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
E.Rodriguez--AT